ORASURE TECHNOLOGIES, INC Tax Withholding Paid on Stock Awards
ORASURE TECHNOLOGIES, INC (OSUR) reported Tax Withholding Paid on Stock Awards of $1.48 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-07
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $223.00K, a 71.56% decline year-over-year.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $1.26M, a 34.01% increase year-over-year.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $57.00K, a 280.00% increase year-over-year.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $61.00K, a 29.89% decline year-over-year.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.84M, a 48.06% decline from fiscal 2024.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for fiscal 2024 was $3.55M, a 86.64% increase from fiscal 2023.
- ORASURE TECHNOLOGIES, INC payment, tax withholding, share-based payment arrangement for fiscal 2023 was $1.90M.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $223.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.48M 10-Q · filed 2026-08-07 | $1.54M derived: sum of 3 quarters · filed 2026-08-07 | $1.60M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $1.26M 10-Q · filed 2026-05-08 | $1.32M derived: sum of 2 quarters · filed 2026-05-08 | $1.38M derived: sum of 3 quarters · filed 2026-05-08 | $2.16M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $57.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $118.00K derived: sum of 2 quarters · filed 2026-03-09 | $902.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.84M 10-K · filed 2026-03-09 |
| 2025-09-30 | $61.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $845.00K derived: sum of 2 quarters · filed 2026-08-07 | $1.79M 10-Q · filed 2025-11-05 | $1.80M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $784.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.73M 10-Q · filed 2026-08-07 | $1.74M derived: sum of 3 quarters · filed 2026-08-07 | $1.83M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $941.00K 10-Q · filed 2026-05-08 | $956.00K derived: sum of 2 quarters · filed 2026-05-08 | $1.04M derived: sum of 3 quarters · filed 2026-05-08 | |
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $102.00K derived: sum of 2 quarters · filed 2026-03-09 | $3.55M 10-K · filed 2026-03-09 | |
| 2024-09-30 | $87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.53M 10-Q · filed 2025-11-05 | ||
| 2024-06-30 | $3.45M 10-Q · filed 2025-08-06 | |||
| 2023-12-31 | $1.90M 10-K · filed 2026-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |